Suraksha Diagnostic Ltd Q2 FY26 Results

Suraksha reported another quarter of strong top-line growth, driven primarily by test volumes. The QoQ and YoY total revenue growth was 8.3% and 16.9%, respectively. We have added 11 centres in H1 of FY26. We are working on 3 hub centres and 6 spoke centres, which will be operational in the second half of FY26, which will take the total count to 20 for the year. In Q1 FY26, we launched Suraksha Genomics, a dedicated vertical offering cutting-edge genetic and molecular testing services. The lab is now fully operational and we expect to leverage the same to drive future growth. As the new centres mature, their margin contributions will increase, moving overall performance closer to industry benchmarks and supporting improved profitability across our network. We remain committed to creating value for our shareholders, driven by innovation, operational excellence and sustainable growth.